Sihuan Pharm

MediaOutReach  

Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China

Led by Top Oncologist Professor Wu Yilong Expected to Commence Phase III Clinical Trial in 2H2019. Demonstrates Strong R&D Capability Solidifies Oncology Drug Development Strategy

Exit mobile version
Silahkan nonaktifkan adblock anda untuk membaca konten kami.
Segarkan